Expert Scientist - Rixensart, België - GSK

GSK
GSK
Geverifieerd bedrijf
Rixensart, België

1 maand geleden

Sophie Dubois

Geplaatst door:

Sophie Dubois

beBee Recruiter


Beschrijving

Site Name:
Belgium-Rixensart


Posted Date:
Nov

Job Purpose


The Expert Scientist is expected to lead, design and execute preclinical scientific studies in support to vaccine project or technological platforms in discovery, development or life cycle management.

They may have as well a team to manage.

Key Responsibilities

  • Lead the design, planning, organization and analysis of preclinical studies (internal and external), including resources forecasts and activity planification
  • Direct management or support to N+1 in development and supervision of lab technicians. This implies an adequate presence to the shop floor where the associated activities are performed. May participate to the performance evaluation, development plan of laboratory staff
  • Share expertise in multiple technical competency domains across the preclinical department BE and possibly across Scientific Areas; Scientific/technology watch in own competency domain within defined mission or project
  • Lead the development of new Read Outs/Laboratory Assays (when applicable)
  • Active participation and presentation of lab results in internal meetings, working groups and technical and project team meetings, ensuring quality interpretation and extensive quality check of raw data
  • Can be the preclinical representative to project teams; when specific expert in one or more techniques, he or she is the principal representative at technical development teams and preferred point of contact for TRD QC, and VCLAP departments with regards to analytical testing or readouts. Autonomous in decision making within own area of scientific or technical competencies with direct impact on related project strategy
  • Autonomous in writing experimental procedures and scientific reports. Significant contribution (autonomous writing and review by N+1) to and direct interactions with the Regulatory/IP teams for the preparation of the preclinical section of Regulatory/IP documents, in own area of technical expertise
  • Responsible for the immunogenicity testing phase (nonGLP conditions) which is part of GLP Toxicity studies, according to the L-SOP9*5529, when applicable
  • Lead the development / qualification of release/characterization assay and testing of Phase I/II vaccine lots before transfer to ARD, when applicable.
  • May coordinate clinical exploratory testing according to best practices and GSK SOP/Policies, when applicable

_ Why you?_:


Basic Qualifications:

  • We are looking for professionals with these required skills to achieve our goals:_
- _ PhD with_ _3+ years of post-doc and/or job related experience _
- _Area of specialisationVirology, virology assays and respiratory viruses_
- _ A good understanding of biopharma/vaccine development process_


Preferred Qualifications:

  • If you have the following characteristics, it would be a plus:_
- _ Must have the ability to work with cross-functional teams and communicate effectively_
- _ Fluent English is a must_
- _ Sound scientific methodology and thinking_
- _ Excellent presentation and communication skills_
- _ Innovative hinking and solution oriented_


_ Why GSK?_:


_ Our values and expectations __are at the heart of everything we do and form an important part of our culture._

  • Committed to delivering high quality results, overcoming challenges, focusing on what matters, execution.
  • Continuously looking for opportunities to learn, build skills and share learning.
  • Sustaining energy and wellbeing
  • Building strong relationships and collaboration, honest and open conversations.
  • Budgeting and costconsciousness
  • Li-GSK


If you have a disability and require assistance during the course of the selection process, you will have the opportunity to let us know what specific assistance you require in order to make suitable arrangements.


Why Us?


GSK is a global biopharma company with a special purpose - to unite science, technology and talent to get ahead of disease together - so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns - as an organization where people can thrive.

Getting ahead means preventing disease as well as treating it, and we aim to positively impact the health of 2.5 billion people by the end of 2030.

Our success absolutely depends on our people.

While getting ahead of disease together is about our ambition for patients and shareholders, it's also about making GSK a place where people can thrive.

We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy.

We're committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.

**Important notice to Employment businesses/ Agencies

Meer banen van GSK